PRSVX
Price
$53.49
Change
-$0.22 (-0.41%)
Updated
Aug 15 closing price
Net Assets
9.87B
VSCPX
Price
$340.19
Change
-$1.26 (-0.37%)
Updated
Aug 15 closing price
Net Assets
154.18B
Interact to see
Advertisement

PRSVX vs VSCPX

Header iconPRSVX vs VSCPX Comparison
Open Charts PRSVX vs VSCPXBanner chart's image
T. Rowe Price Small-Cap Value
Price$53.49
Change-$0.22 (-0.41%)
VolumeN/A
Net Assets9.87B
Vanguard Small Cap Index InstlPlus
Price$340.19
Change-$1.26 (-0.37%)
VolumeN/A
Net Assets154.18B
PRSVX vs VSCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PRSVX vs. VSCPX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRSVX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 154B vs. PRSVX (9.87B). VSCPX pays higher dividends than PRSVX: VSCPX (1.39) vs PRSVX (0.85). PRSVX was incepted earlier than VSCPX: PRSVX (37 years) vs VSCPX (15 years). PRSVX (0.77) is less costly to investors than VSCPX (0.03). PRSVX is a more actively managed with annual turnover of: 32.40 vs. VSCPX (13.00). PRSVX has a lower initial minimum investment than VSCPX: PRSVX (2500) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 9.18 vs. PRSVX (-1.87). VSCPX return over 5 years is better than : 57.76 vs. PRSVX (23.71).
PRSVXVSCPXPRSVX / VSCPX
Total Expense Ratio0.770.032,567%
Annual Report Gross Expense Ratio0.770.032,567%
Fund Existence37 years15 years-
Gain YTD1.3262.52852%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.87B154B6%
Annual Yield % from dividends0.851.3961%
Returns for 1 year-1.879.18-20%
Returns for 3 years-5.0220.50-24%
Returns for 5 years23.7157.7641%
Returns for 10 years19.60113.1917%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
EWTX14.150.22
+1.58%
Edgewise Therapeutics
RYAN59.12-0.39
-0.66%
Ryan Specialty Holdings
MBINM25.19-0.18
-0.72%
Merchants Bancorp
ALT3.63-0.05
-1.36%
Altimmune